Home / Stocks / ORCL

Oracle (ORCL, Systems Software) Stock Valuation & Fair Value Mixed on our tests

Oracle (ORCL, Systems Software) trades at a blended P/E of 18.3, about 9% above its historical normal valuation, with a forward growth estimate of 30.0% and a PEG of 0.61. Analysts' one-year estimates have been hit 64% of the time. Priced at its historical normal P/E of 16.7 on the same blended earnings, the 2026-10-02 close of $142.30 corresponds to about $130 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-10-05
Blended P/E
18.3
Normal P/E
16.7
PEG
0.61
Fwd growth
30.0%
Div yield
1.4%
RSI (14)
41.5
Neutral
Technical context
  • Price $135.69 at the 2026-10-08 close, 4.8% below the 20-day average ($142.52) and 6.7% below the 50-day ($145.47).
  • RSI (14) at 41.5.
  • 52-week range $114.99 to $310.01: the price is 56.2% below the high and 18.0% above the low.
  • Across its last 2 earnings reports the options market priced a median 12.7% move.

The Street vs SeerForecast

Wall Street's mean price target for ORCL is $237.97 across 41 analysts, 75.4% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from significantly overvalued (2026-06-03) to mixed on our tests (2026-10-05).

Blended P/E and rating by weekBlended P/E moved from 27.2 to 18.3 between 2026-06-03 and 2026-10-02, against a normal P/E of 16.7, with 5 rating changes over 36 recorded weeks.2026-06-03: P/E 27.2, Significantly overvalued, recalculated for the week of 2026-06-032026-06-10: P/E 28.5, Significantly overvalued, recalculated for the week of 2026-06-102026-06-12: P/E 28.5, Significantly overvalued, recalculated for the week of 2026-06-142026-06-16: P/E 28.5, Significantly overvalued, recalculated for the week of 2026-06-162026-06-18: P/E 28.5, Significantly overvalued, recalculated for the week of 2026-06-212026-07-02: P/E 18.6, Mixed on our tests, recalculated for the week of 2026-07-022026-07-06: P/E 18.3, Mixed on our tests, recalculated for the week of 2026-07-062026-07-09: P/E 18.3, Mixed on our tests, recalculated for the week of 2026-07-092026-07-10: P/E 18.3, Mixed on our tests, recalculated for the week of 2026-07-122026-07-13: P/E 18.3, Mixed on our tests, recalculated for the week of 2026-07-132026-07-14: P/E 18.3, Mixed on our tests, recalculated for the week of 2026-07-142026-07-20: P/E 16.4, Mixed on our tests, recalculated for the week of 2026-07-202026-07-22: P/E 16.4, Mixed on our tests, recalculated for the week of 2026-07-222026-07-24: P/E 14.9, Mixed on our tests, recalculated for the week of 2026-07-252026-07-27: P/E 14.9, Mixed on our tests, recalculated for the week of 2026-07-272026-07-31: P/E 16.9, Mixed on our tests, recorded live 2026-08-032026-08-07: P/E 18.6, Mixed on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 19.1, Mixed on our tests, recorded live 2026-08-102026-08-14: P/E 20.2, Trading above its usual valuation, recalculated for the week of 2026-08-142026-08-14: P/E 19.5, Mixed on our tests, recorded live 2026-08-172026-08-21: P/E 18.4, Mixed on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 19.0, Mixed on our tests, recorded live 2026-08-242026-08-27: P/E 19.0, Mixed on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 19.6, Mixed on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 19.5, Mixed on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 19.5, Mixed on our tests, recorded live 2026-08-312026-09-04: P/E 20.5, Trading above its usual valuation, recalculated for the week of 2026-09-052026-09-04: P/E 20.5, Trading above its usual valuation, recorded live 2026-09-072026-09-11: P/E 19.4, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 19.4, Mixed on our tests, recorded live 2026-09-142026-09-18: P/E 19.0, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 19.0, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 17.6, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 17.6, Mixed on our tests, recorded live 2026-09-282026-10-02: P/E 18.3, Mixed on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 18.3, Mixed on our tests, recorded live 2026-10-0515.020.025.0Jun 3Jul 3Aug 2Sep 2Oct 2Normal P/E 16.7
Mixed on our testsTrading above its usual valuationSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 27.2+68%Significantly overvalued (recalculated)
2026-06-10P/E 28.5+75%Significantly overvalued (recalculated)
2026-07-02P/E 18.6+11%Mixed on our tests (recalculated)
2026-07-25P/E 14.9-10%Mixed on our tests (recalculated)
2026-08-14P/E 20.2+21%Trading above its usual valuation (recalculated)
2026-08-17P/E 19.5+17%Mixed on our tests
2026-09-05P/E 20.5+23%Trading above its usual valuation (recalculated)
2026-09-12P/E 19.4+16%Mixed on our tests (recalculated)
2026-10-05P/E 18.3+9%Mixed on our tests ← now
Show all 36 weeks
WeekBlended P/EPremium to normal P/ERating
2026-06-03P/E 27.2+68%Significantly overvalued (recalculated)
2026-06-10P/E 28.5+75%Significantly overvalued (recalculated)
2026-06-14P/E 28.5+75%Significantly overvalued (recalculated)
2026-06-16P/E 28.5+75%Significantly overvalued (recalculated)
2026-06-21P/E 28.5+75%Significantly overvalued (recalculated)
2026-07-02P/E 18.6+11%Mixed on our tests (recalculated)
2026-07-06P/E 18.3+10%Mixed on our tests (recalculated)
2026-07-09P/E 18.3+10%Mixed on our tests (recalculated)
2026-07-12P/E 18.3+10%Mixed on our tests (recalculated)
2026-07-13P/E 18.3+10%Mixed on our tests (recalculated)
2026-07-14P/E 18.3+10%Mixed on our tests (recalculated)
2026-07-20P/E 16.4-1%Mixed on our tests (recalculated)
2026-07-22P/E 16.4-1%Mixed on our tests (recalculated)
2026-07-25P/E 14.9-10%Mixed on our tests (recalculated)
2026-07-27P/E 14.9-10%Mixed on our tests (recalculated)
2026-08-03P/E 16.9+1%Mixed on our tests
2026-08-07P/E 18.6+12%Mixed on our tests (recalculated)
2026-08-10P/E 19.1+14%Mixed on our tests
2026-08-14P/E 20.2+21%Trading above its usual valuation (recalculated)
2026-08-17P/E 19.5+17%Mixed on our tests
2026-08-21P/E 18.4+10%Mixed on our tests (recalculated)
2026-08-24P/E 19.0+14%Mixed on our tests
2026-08-27P/E 19.0+14%Mixed on our tests (recalculated)
2026-08-28P/E 19.6+18%Mixed on our tests (recalculated)
2026-08-30P/E 19.5+17%Mixed on our tests (recalculated)
2026-08-31P/E 19.5+17%Mixed on our tests
2026-09-05P/E 20.5+23%Trading above its usual valuation (recalculated)
2026-09-07P/E 20.5+23%Trading above its usual valuation
2026-09-12P/E 19.4+16%Mixed on our tests (recalculated)
2026-09-14P/E 19.4+16%Mixed on our tests
2026-09-19P/E 19.0+14%Mixed on our tests (recalculated)
2026-09-21P/E 19.0+14%Mixed on our tests
2026-09-26P/E 17.6+6%Mixed on our tests (recalculated)
2026-09-28P/E 17.6+6%Mixed on our tests
2026-10-03P/E 18.3+9%Mixed on our tests (recalculated)
2026-10-05P/E 18.3+9%Mixed on our tests ← now

Earnings moves: ORCL moved more than the options market implied in 0 of 2 recent tracked reports.

Frequently asked questions

Is Oracle stock overvalued?

At a blended P/E of 18.3 versus its historical normal P/E of 16.7, Oracle trades about 9% above its typical valuation, with a PEG of 0.61 on 30.0% forward growth. tickerseer currently rates it mixed on our tests.

What is Oracle's fair value and PEG?

Oracle trades at a blended P/E of 18.3 against a historical normal P/E of 16.7, a PEG of 0.61, and a forward growth estimate of 30.0%. Priced at its historical normal P/E of 16.7 on the same blended earnings, the 2026-10-02 close of $142.30 corresponds to about $130 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Oracle changed?

tickerseer's rating moved from significantly overvalued (2026-06-03) to mixed on our tests (2026-10-05).

What is the analyst price target for Oracle?

The mean Wall Street price target for Oracle is $237.97 across 41 analysts, 75.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Systems Software. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ORCL free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.